foams and jellies vaginal creams

Summary

Summary: Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent.

Top Publications

  1. ncbi The effect of pH on release of PGE2 from vaginal and endocervical preparations for induction of labour: an in-vitro study
    T A Johnson
    Department of Obstetrics and Gynaecology, University of Edinburgh, UK
    Br J Obstet Gynaecol 99:877-80. 1992
  2. ncbi Awareness and practice of family planning methods in women attending gyne OPD at Nepal Medical College Teaching Hospital
    H Tuladhar
    Department of Obs Gyne, Nepal Medical College Teaching Hospital, Jorpati, Kathmandu, Nepal
    Nepal Med Coll J 10:184-91. 2008
  3. pmc Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial
    K S Oppegaard
    Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest, Hammerfest, Norway
    BJOG 115:917-e10. 2008
  4. ncbi Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S for cervical ripening before first trimester curettage
    Frank Chih Kang Chen
    Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Klinik fur Geburtsmedizin, Augustenburger Platz 1, Berlin, Germany
    Eur J Obstet Gynecol Reprod Biol 138:176-9. 2008
  5. pmc A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial
    K S Oppegaard
    Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest, Hammerfest, Norway
    BJOG 117:53-61. 2010
  6. ncbi Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion
    Matthias David
    Department of Gynecology and Obstetrics, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Arch Gynecol Obstet 273:144-5. 2005
  7. ncbi Termination of pregnancy in patients with previous cesarean section
    Chafika Mazouni
    Department of Obstetrics and Gynecology, Conception Hospital, 13385 Marseille, France
    Contraception 73:244-8. 2006
  8. ncbi ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel]
    P Cepicky
    Gynekologicko porodnická ambulance LEVRET s r o, Praha
    Ceska Gynekol 70:232-7. 2005
  9. ncbi Men's knowledge of and attitude with respect to family planning in a suburban Nigerian community
    O O Odu
    Department of Community Medicine, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria
    Niger J Med 15:260-5. 2006
  10. ncbi Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel
    Anastasia Rivkin
    Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Brooklyn, New York 11201, USA
    Pharmacotherapy 27:1058-61. 2007

Research Grants

Detail Information

Publications133 found, 100 shown here

  1. ncbi The effect of pH on release of PGE2 from vaginal and endocervical preparations for induction of labour: an in-vitro study
    T A Johnson
    Department of Obstetrics and Gynaecology, University of Edinburgh, UK
    Br J Obstet Gynaecol 99:877-80. 1992
    ....
  2. ncbi Awareness and practice of family planning methods in women attending gyne OPD at Nepal Medical College Teaching Hospital
    H Tuladhar
    Department of Obs Gyne, Nepal Medical College Teaching Hospital, Jorpati, Kathmandu, Nepal
    Nepal Med Coll J 10:184-91. 2008
    ..Efforts should be made to educate the public about the safety and convenience of modern, long-term, reversible methods of contraception among both healthcare professionals and the public...
  3. pmc Does self-administered vaginal misoprostol result in cervical ripening in postmenopausal women after 14 days of pre-treatment with estradiol? Trial protocol for a randomised, placebo-controlled sequential trial
    K S Oppegaard
    Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest, Hammerfest, Norway
    BJOG 115:917-e10. 2008
    ....
  4. ncbi Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan-S for cervical ripening before first trimester curettage
    Frank Chih Kang Chen
    Charite Universitatsmedizin Berlin, Campus Virchow Klinikum, Klinik fur Geburtsmedizin, Augustenburger Platz 1, Berlin, Germany
    Eur J Obstet Gynecol Reprod Biol 138:176-9. 2008
    ..To compare the efficacy and safety of vaginal applications of three different principles of cervical priming prior to first trimester curettage, isosorbide mononitrate (ISMN), misoprostol and Dilapan-S, a hygroscopical cervical dilator...
  5. pmc A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial
    K S Oppegaard
    Department of Gynaecology, Helse Finnmark, Klinikk Hammerfest, Hammerfest, Norway
    BJOG 117:53-61. 2010
    ....
  6. ncbi Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion
    Matthias David
    Department of Gynecology and Obstetrics, Charite, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany
    Arch Gynecol Obstet 273:144-5. 2005
    ..The objective of this study was to compare NO-donor isosorbide mononitrate to misoprostol, both applied as vaginal tablets for cervical ripening prior to first trimester curettage in patients with missed abortion...
  7. ncbi Termination of pregnancy in patients with previous cesarean section
    Chafika Mazouni
    Department of Obstetrics and Gynecology, Conception Hospital, 13385 Marseille, France
    Contraception 73:244-8. 2006
    ..To evaluate the safety and efficacy of termination of pregnancy using mifepristone and misosprostol at more than 15 weeks' gestation in patients with uterine scar due to previous cesarean section...
  8. ncbi ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal administration of nystatin and nifuratel]
    P Cepicky
    Gynekologicko porodnická ambulance LEVRET s r o, Praha
    Ceska Gynekol 70:232-7. 2005
    ..The evaluation of combined and miscellaneous vulvovaginal infections incidence and their treatment with combined vaginal products containing nifuratel and nystatin...
  9. ncbi Men's knowledge of and attitude with respect to family planning in a suburban Nigerian community
    O O Odu
    Department of Community Medicine, College of Health Sciences, Ladoke Akintola University of Technology, Osogbo, Osun State, Nigeria
    Niger J Med 15:260-5. 2006
    ..A cross-sectional survey was conducted to determine men's knowledge of and attitude to family planning at Ganmo, a sub-urban community on the outskirts of Ilorin, Nigeria...
  10. ncbi Thrombotic thrombocytopenic purpura induced by metronidazole vaginal gel
    Anastasia Rivkin
    Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Brooklyn, New York 11201, USA
    Pharmacotherapy 27:1058-61. 2007
    ..This patient had developed TTP after only one exposure to metronidazole vaginal gel. Clinicians should be aware of this life-threatening adverse reaction to a commonly prescribed drug...
  11. pmc Oral misoprostol for induction of labour at term: randomised controlled trial
    Jodie M Dodd
    Department of Obstetrics and Gynaecology, University of Adelaide, Women s and Children s Hospital, North Adelaide, SA 5006, Australia
    BMJ 332:509-13. 2006
    ..To compare oral misoprostol solution with vaginal prostaglandin gel (dinoprostone) for induction of labour at term to determine whether misoprostol is superior...
  12. ncbi A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses
    Werner Mendling
    Vivantes Klinka im Friedrichshain und Am Urban, Klinik für Gynäkologie und Geburtsmedizin, Berlin, Germany
    Mycoses 47:136-42. 2004
    ..All treatments administered were safe and well-tolerated and the number of patients experiencing adverse events was low...
  13. ncbi Metronidazole with Lactacyd vaginal gel in bacterial vaginosis
    Ditas Cristina D Decena
    University Santo Tomas Hospital, Manila, Philippines
    J Obstet Gynaecol Res 32:243-51. 2006
    ..To assess the efficacy and tolerability of lactic acid (Lactacyd vaginal gel; LVG) when given as an adjunct to metronidazole in the treatment of bacterial vaginosis (BV) among Filipino patients...
  14. ncbi [Ketoconazole and clindamycin efficacy vs oral clindamycin in premature membranes rupture prevention]
    Eugenio Castillo Huerta
    Servicio de Ginecologia y Obstetricia, Ginecoobstetra certificado por el Consejo Mexicano de Ginecología y Obstetricia, Hospital Civil Dr Miguel Silva SSA de Morelia, Michoacan, Mexico
    Ginecol Obstet Mex 76:373-80. 2008
    ..Vulvovaginitis is one of the main causes of premature membrane rupture...
  15. ncbi [Indication for labor induction by prostaglandin E2 vaginal gel. Retrospective study of a continuous series of 170 patients]
    Lionel Carbillon
    Service de Gynécologie Obstétrique Hôpital Jean Verdier Assistance Publique Hôpitaux de Paris Avenue du 14 Juillet 93143 Bondy
    Presse Med 31:594-600. 2002
    ..To assess the factors of efficacy, side effects and complications following vaginal application of prostaglandin E2 (PGE2)...
  16. ncbi Estrogen and progesterone effects on transcapillary fluid dynamics
    N S Stachenfeld
    The John B Pierce Laboratory and Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Am J Physiol Regul Integr Comp Physiol 281:R1319-29. 2001
    ..05), and the PV loss during ANP infusion was attenuated (-0.9 +/- 0.2 and -0.2 +/- 0.2 ml/kg for GnRH analog-alone and E(2)-P(4) treatments, respectively). Thus the E(2)-P(4) treatment lowered CFC and reduced PV loss during ANP infusion...
  17. doi Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis
    P Mastromarino
    Department of Public Health Sciences, Section of Microbiology, Universita Sapienza, Rome, Italy
    Clin Microbiol Infect 15:67-74. 2009
    ..The data indicate that intravaginal administration of exogenous selected strains of lactobacilli can restore a normal vaginal microbiota and be used in treating bacterial vaginosis...
  18. ncbi Induction of labor with prostaglandin E2 in women with previous cesarean section and unfavorable cervix
    Yariv Yogev
    Perinatal Division and WHO Collaborating Center, Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tikva 49100, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Obstet Gynecol Reprod Biol 116:173-6. 2004
    ..To study the pregnancy outcome of induction of labor with prostaglandin E2 (PGE2) in women with one previous lower segment cesarean section...
  19. doi A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women
    Michael J Gast
    Wyeth Pharmaceuticals, Collegeville, PA, USA
    Menopause 16:247-56. 2009
    ..To evaluate the effects of combined vaginal and oral low-dose estrogen plus progestogen therapy (EPT) on the frequency and severity of dyspareunia, sexual function, and quality of life in recently postmenopausal women...
  20. ncbi [Antifungal effect in selected natural compounds and probiotics and their possible use in prophylaxis of vulvovaginitis]
    M Hronek
    Katedra biologických a lékarských vĕd Farmaceutické fakulty v Hradci Králové, LF UK, Praha
    Ceska Gynekol 70:395-9. 2005
    ..a survey of effective natural compounds and probiotics with antifungal activity and their possible use in vulvovaginitis as a prophylactic or therapeutic drug...
  21. ncbi Lidocaine vaginal gel versus lidocaine paracervical block for analgesia during oocyte retrieval
    Ian Tummon
    Department of Obstetrics and Gynaecology, The University of Western Ontario, London, Ontario, Canada
    Hum Reprod 19:1116-20. 2004
    ..Vaginal application of lidocaine gel is a non-invasive alternative to lidocaine paracervical block. The goal of the present trial was to compare analgesia with lidocaine vaginal gel versus lidocaine paracervical block...
  22. doi A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis
    M Simbar
    School of Midwifery, Shahid Beheshti Medical Science University, Tehran, Iran
    Phytomedicine 15:1025-31. 2008
    ..multiflora vaginal cream are similar to metronidazole vaginal gel on BV. Therefore it could be an appropriate choice to BV treatment for those interested in herbal medicines or those affected by side effects of metronidazole...
  23. ncbi Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial
    Massimo Milani
    R and D Mipharm, Via B Quaranta 12, 20141 Milan, Italy
    Eur J Obstet Gynecol Reprod Biol 109:67-71. 2003
    ..To evaluate the efficacy of tinidazole (T) (Trimonase, Mipharm, Italy) and an acidic vaginal gel (Miphil) (M) in comparison with vaginal clindamycin (CL) (Cleocin Pharmacia Upjohn) in BV...
  24. ncbi Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial
    J M O'Brien
    Perinatal Diagnostic Center, Central Baptist Hospital, Lexington, Kentucky, USA
    Ultrasound Obstet Gynecol 30:687-96. 2007
    ..The objective of this trial was to determine whether prophylactic administration of vaginal progesterone reduces the risk of preterm birth in women with a history of spontaneous preterm birth...
  25. ncbi Management of post-menopausal vaginal atrophy and atrophic vaginitis
    Camil Castelo-Branco
    Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, Facultad de Medicina, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
    Maturitas 52:S46-52. 2005
    ..This review focuses on the changes involved in vaginal aging and efforts to present a synopsis of the pathophysiology and therapy of atrophic vaginitis and vaginal atrophy...
  26. ncbi Preinduction cervical ripening with prostaglandin E2 at preterm
    Nir Melamed
    Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Hospital, Petah Tiqva, Israel
    Acta Obstet Gynecol Scand 87:63-7. 2008
    ..To evaluate the efficacy of prostaglandin E2 (PGE2) for cervical ripening at preterm and to identify factors predicting ripening failure...
  27. ncbi [Comparative efficacy of vaginal insert and dinoprostone gel for cervical ripening at term in current practice]
    C Denoual-Ziad
    Service Gynécologie Obstétrique et Médecine de la Reproduction, CHU, Caen
    J Gynecol Obstet Biol Reprod (Paris) 34:62-8. 2005
    ..To compare efficiency for slow release vaginal insert and vaginal gel in current practice...
  28. ncbi The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis
    M Minozzi
    Institute of Gynecology and Obstetrics, University La Sapienza, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:59-65. 2008
    ....
  29. ncbi Single-dose sertaconazole vaginal tablet treatment of vulvovaginal candidiasis
    Peng Hui Wang
    Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan, ROC
    J Chin Med Assoc 69:259-63. 2006
    ..The aim of the present study was to evaluate the efficacy, acceptability, and safety of single-dose sertaconazole vaginal tablet (500 mg) treatment compared with conventional 3-dose econazole vaginal tablet (150 mg) treatment for VVC...
  30. pmc A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women
    L Van Damme
    Institute of Tropical Medicine, Antwerp, Belgium
    Sex Transm Infect 76:126-30. 2000
    ..5% and 4%) over a 2 week period of daily exposure in two cohorts of healthy sexually abstinent women (one in London, UK, and the other in Antwerp, Belgium)...
  31. ncbi A universal combination treatment for vaginitis
    Jacob Bornstein
    Department of Obstetrics and Gynecology, Western Galilee Hospital, Nahariya, Israel
    Gynecol Obstet Invest 65:195-200. 2008
    ..We compared a novel vaginal tablet consisting of 100 mg of clotrimazole and 100 mg of metronidazole ('Clo-Met') to a 100-mg clotrimazole tablet in the treatment of vaginitis...
  32. pmc Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections
    Mohd Aftab Alam
    Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi 110062, India
    AAPS PharmSciTech 8:E109. 2007
    ..In the in vitro antimicrobial study it was found that the acid-buffering bioadhesive tablet produces better antimicrobial action than marketed intravaginal drug delivery systems (Infa-V, Candid-V and Canesten 1)...
  33. ncbi Effect of long-term local or systemic hormone replacement therapy on post-menopausal mood disturbances. Influences of socio-economic and personality factors
    A Cagnacci
    Institute of Obstetrics and Gynecology, University of Modena, Italy
    Maturitas 31:111-6. 1999
    ..To clarify the effect exerted by hormone replacement therapy (HRT) versus socio-economic and personality factors in improving postmenopausal mood disorders...
  34. pmc Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception
    Vivian Brache
    PROFAMILIA, Biomedical Research Department, P O Box 1053, Santo Domingo 10401, Dominican Republic
    Contraception 76:111-6. 2007
    ..75 mg of levonorgestrel (CARRA/LNG gel) administered in a single dose at different stages of follicle development over subsequent follicle rupture and hormonal levels...
  35. pmc Effect of thiolated polymers to textural and mucoadhesive properties of vaginal gel formulations prepared with polycarbophil and chitosan
    Erdal Cevher
    Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul University, 34116, Istanbul, Turkey
    AAPS PharmSciTech 9:953-65. 2008
    ..Stability of CLM was preserved during the 3 month stability analysis under controlled room temperature and accelerated conditions...
  36. pmc Luteal phase bleeding after IVF cycles: comparison between progesterone vaginal gel and intramuscular progesterone and correlation with pregnancy outcomes
    Sami Jabara
    Department of Obstetrics and Gynecology, Texas Tech University, Lubbock, Texas, USA
    J Exp Clin Assist Reprod 6:6. 2009
    ..To compare luteal phase bleeding and pregnancy outcomes in normogonadotropic patients receiving progesterone vaginal gel (PVG) or intramuscular progesterone (IMP) injections...
  37. doi A phase II randomized controlled trial to evaluate the safety and efficacy of Praneem polyherbal vaginal tablets compared with betadine vaginal pessary in women with symptoms of abnormal vaginal discharge
    Sudha Salhan
    Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
    Asia Pac J Public Health 21:461-8. 2009
    ..Thus, the study indicates the efficacy of Praneem for the treatment of AVD and provides a rationale for planning a further Phase III study on a larger sample size for definitive conclusions...
  38. ncbi Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans
    Lynn K Pershing
    Department of Dermatology, University of Utah School of Medicine, Salt Lake City 84132, USA
    Pharm Res 19:270-7. 2002
    ..To compare the dermatopharmacokinetic vs. clinical trial methods for bioequivalence assessment of two miconazole nitrate vaginal cream, 2% products...
  39. ncbi 17 alpha-hydroxyprogesterone caproate versus intravaginal progesterone in IVF-embryo transfer cycles: a prospective randomized study
    Vittorio Unfer
    A G UN CO, Obstetrics and Gynecology Centre, via G Cassiani, 15 00155 Rome, Italy
    Reprod Biomed Online 9:17-21. 2004
    ..The data showed that 17-HPC administered every 3 days appears to be more effective in providing luteal support in comparison to intra-vaginal progesterone...
  40. ncbi Cervical ripening with the Foley catheter
    A Cromi
    Department of Obstetrics and Gynecology, University of Insubria Ospedale F Del Ponte, Varese, Italy
    Int J Gynaecol Obstet 97:105-9. 2007
    ..To evaluate maternal and neonatal outcomes in a large series of patients undergoing cervical ripening with a Foley catheter...
  41. ncbi Urinary tract infections in pregnant women with bacterial vaginosis
    S H Sharami
    Department of Obstetrics and Gynecology, Guilan University of Medical Sciences, Rasht, Iran
    J Obstet Gynaecol 27:252-4. 2007
    ..8%) of those without. Bacterial vaginosis was associated with an increased risk of UTIs (odds ratio (OR) 3.05; 95% CI: 1.47-6.33). Pregnant women with bacterial vaginosis are at increased risk for UTIs...
  42. ncbi Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel
    Vorapann Mahaguna
    PharmaForm, LLC, Austin, TX 78758, USA
    Drug Dev Ind Pharm 30:1069-78. 2004
    ..This data indicates that pharmacy compounded delivery systems for progesterone should be used with caution...
  43. ncbi Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
    Lut Van Damme
    Institute of Tropical Medicine, Antwerp, Belgium
    Lancet 360:971-7. 2002
    ..Results of studies of its effectiveness in prevention of HIV-1 infection in women have been inconclusive. We aimed to assess effectiveness of this vaginal gel...
  44. doi Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission
    Jie Yang
    School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China
    AIDS Res Hum Retroviruses 28:1498-508. 2012
    ....
  45. pmc Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
    Dhs Tan
    Divisions of Infectious Diseases, St Michael s Hospital, University, Health Network, and University of Toronto, Toronto, Canada
    Int J Womens Health 4:341-50. 2012
    ..This article reviews the currently available data for tenofovir as an anti-herpes agent, as well as unanswered questions about delivery systems, drug formulation, rectal administration, drug resistance, and clinical applications...
  46. ncbi Preparation of cycles for cryopreservation transfers using estradiol patches and Crinone 8% vaginal gel is effective and does not need any monitoring
    C Banz
    Department of Gynecology and Obstetrics, University Hospital, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Obstet Gynecol Reprod Biol 103:43-7. 2002
    ..The estradiol serum level did not predict success. In conclusion, this method of endometrial preparation is comfortable for patients and monitoring is unnecessary...
  47. pmc An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India
    Sharon A Abbott
    Population Council, New York, NY, USA
    AIDS Behav 17:2222-36. 2013
    ..Compliance to IVRS was low, despite familiarity with mobile phone technology. Additional explorations with other populations are needed...
  48. pmc Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy
    U Jaisamrarn
    Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    Climacteric 16:347-55. 2013
    ..03 mg in combination with viable Lactobacillus acidophilus KS400 (Gynoflor(®) vaginal tablets) in the short-term therapy and to investigate the long-term maintenance dose in the treatment of vaginal atrophy...
  49. pmc MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments
    Craig W Hendrix
    Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
    PLoS ONE 8:e55013. 2013
    ....
  50. pmc In vivo optical imaging of human vaginal gel thickness distributions with a probe-based, dual-modality instrument
    Tyler K Drake
    Duke University, Department of Biomedical Engineering, Durham, North Carolina 27708, USA
    J Biomed Opt 17:116014. 2012
    ....
  51. doi Progesterone vaginal ring versus vaginal gel for luteal support with in vitro fertilization: a randomized comparative study
    Laurel Stadtmauer
    Jones Institute for Reproductive Medicine, Norfolk, Virginia 23507, USA
    Fertil Steril 99:1543-9. 2013
    ..To compare the efficacy and safety of luteal phase support in IVF with a progesterone (P) vaginal ring or gel (VR or VG)...
  52. ncbi Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment
    J D Wilson
    Department of Genitourinary Medicine, The General Infirmary at Leeds, Great George Street, Leeds LS1 3EX, UK janet_d wilson nhs uk
    Int J STD AIDS 16:736-8. 2005
    ..4 per woman/year, and this was reduced to 0.6 recurrences per woman/year. As there are few effective therapies for women with recurrent BV, we feel this offers an option that can currently be used in clinical practice...
  53. doi Acceptability of coitally-associated versus daily use of 1% tenofovir vaginal gel among women in Pune, India
    Sanjay Mehendale
    National Institute of Epidemiology, R 127, 3rd Avenue, Tamil Nadu Housing Board, Ayapakkam, Chennai 600077, India
    Int Health 4:63-9. 2012
    ..Leakage was a problem that requires attention. Positioning of the product in a setting such as India where the majority of decision-making is done by men would need extensive and systematic education of men. ..
  54. pmc Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive
    Marla J Keller
    Department of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America
    PLoS ONE 7:e46901. 2012
    ..This study was designed to evaluate the safety of vaginal dosing and effects of Acidform on mucosal immune mediators, antimicrobial properties of genital secretions, and vaginal microbiota...
  55. ncbi Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging
    Kurt T Barnhart
    Center for Reproductive Medicine and Surgery, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Contraception 71:357-61. 2005
    ..Repeat application of the gel may be necessary if intercourse has not occurred within the first few hours after initial insertion...
  56. ncbi Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction
    Jose Guilherme Cecatti
    Department of Obstetrics and Gynecology, School of Medical Sciences FCM, University of Campinas, SP, Brazil
    Acta Obstet Gynecol Scand 85:706-11. 2006
    ....
  57. doi Design of tenofovir-UC781 combination microbicide vaginal gels
    Patrick F Kiser
    Department of Bioengineering, University of Utah, Salt Lake City, Utah 84112 5820, USA
    J Pharm Sci 101:1852-64. 2012
    ..The approach described herein provides a rational schema to design and evaluate vaginal gels for use as microbicides...
  58. doi Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial
    Junya Chen
    Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China
    J Sex Med 10:1575-84. 2013
    ..Estrogen-based treatments have been shown to be effective; however, many patients are reluctant to use such formulations due to health concerns, hence the need to assess the efficacy of acceptable alternatives...
  59. pmc Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis
    Abhijit A Date
    School of Pharmacy and Health Professions, Creighton University, Omaha, NE 68178, USA
    Antiviral Res 96:430-6. 2012
    ..These data demonstrate the potential of antiretroviral NP-embedded vagina gels for long-term vaginal pre-exposure prophylaxis of heterosexual HIV-1 transmission...
  60. ncbi Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa
    Janneke H H M van de Wijgert
    Population Council, New York, NY, USA
    J Acquir Immune Defic Syndr 46:538-46. 2007
    ..To assess the safety of the candidate microbicide Carraguard gel in HIV-positive women and men...
  61. pmc Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis
    F Boselli
    Department of Obstetrics and Gynecology, University Hospital, 4121 Modena, Italy
    ISRN Obstet Gynecol 2012:183403. 2012
    ..All the treatments were well tolerated, with only minor local adverse events infrequently reported. The results of this study confirmed that gynaecological Fitostimoline is a safe and effective topical treatment for BV...
  62. pmc Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial
    Lynn T Matthews
    Massachusetts General Hospital, Division of Infectious Disease, Center for Global Health, Boston, Massachusetts, USA
    PLoS ONE 8:e56400. 2013
    ..Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy...
  63. pmc Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities
    A Vandebosch
    Ghent University, Ghent, Belgium Medical Research Council, Durban, South Africa
    Sex Transm Infect 80:241-3. 2004
    ..To evaluate the acceptability of COL-1492, a vaginal gel containing 52.5 mg nonoxynol-9, in an HIV prevention trial...
  64. ncbi [Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial]
    Sylvie Bazin
    Service d Obstétrique Gynécologie, Centre Hospitalier Universitaire de Quebec
    J Obstet Gynaecol Can 33:838-43. 2011
    ..Our objective was to assess the short-term effect of an estrogen cream on symptoms associated with provoked vestibulodynia...
  65. ncbi In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
    Deborah Tien
    Biosyn, Inc, Huntingdon Valley, PA 19006, USA
    AIDS Res Hum Retroviruses 21:845-53. 2005
    ....
  66. ncbi [Gynecological aspects of allogenic stem cell transplantation--incidence, risk factors and preventive strategies--description of two clinical cases and literature review]
    Tomasz Rechberger
    II Katedra i Klinika Ginekologii UM w Lublinie, Polska
    Ginekol Pol 84:807-10. 2013
    ..After 6 weeks a follow up revealed complete healing of the vaginal canal and both patients resumed uneventful sexual intercourses. A literature review of preventive strategies for vaginal GVHD was also presented...
  67. ncbi The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study
    Antonio Cano
    Pediatrics Obstetrics and Gynecology Department, Valencia University, HU Dr Preset, Valencia, Spain
    Menopause 19:1130-9. 2012
    ..005% estriol vaginal gel), providing an ultra low dose of estriol per application (50 μg), for the local treatment of postmenopausal vaginal atrophy...
  68. ncbi Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections
    Bruno Molteni
    Obstetric and Gynecology Department Ospedale Civile, Giussano, Italy
    Curr Med Res Opin 20:849-53. 2004
    ..Clinical cure rate was assessed at the end of the study (week 4) by an investigator unaware of the patient's treatment allocation...
  69. ncbi Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women
    M Stomati
    Department of Obstetrics and Gynecology, University of Pisa, Italy
    Maturitas 28:127-35. 1997
    ..Vasomotor and behavioral effects were evaluated by using the Kupperman score, while changes in plasma endorphin (beta-END) levels were used as marker of neuroendocrine effects...
  70. doi Induction of labour in nulliparous and multiparous women: a UK, multicentre, open-label study of intravaginal misoprostol in comparison with dinoprostone
    A A Calder
    Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, UK
    BJOG 115:1279-88. 2008
    ..To compare the efficacy and safety of a 25-microgram vaginal tablet of misoprostol (APL202) with dinoprostone (3-mg vaginal tablet) in cervical ripening and labour induction...
  71. ncbi Prostaglandin E vaginal gel to treat dystocia in spontaneous labour: a multicentre randomised placebo-controlled trial
    Lawrence W Oppenheimer
    Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa Hospital General Campus, Rm 8420, Ottawa, Ontario, Canada K1H 8L6
    BJOG 112:612-8. 2005
    ..To test the safety and efficacy of prostaglandin E(2) (PgE(2)) as a treatment for dystocia in spontaneous labour...
  72. doi Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery
    Shailesh V Biradar
    Department of Pharmaceutics, Bharati Vidyapeeth University, Poona College of Pharmacy, Maharashtra State, India
    Pharm Dev Technol 14:38-49. 2009
    ..As MHT may not produce discomfort and interference, it will be preferred over bioadhesive gel or tablet...
  73. pmc The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy
    Ronald F Lamont
    Northwick Park and St Mark s NHS Trust, Harrow, Middlesex, London, UK
    Infect Dis Obstet Gynecol 11:181-9. 2003
    ..To assess the efficacy of 2% clindamycin vaginal cream (CVC) to treat bacterial vaginosis (BV) in pregnancy...
  74. ncbi A randomized trial of vaginal prostaglandin E2 for induction of labor. Insert vs. tablet
    Michaela Rabl
    Department of Obstetrics and Gynecology, University of Vienna, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    J Reprod Med 47:115-9. 2002
    ..To compare the efficacy and safety of a prostaglandin E2 (PGE2) vaginal insert with PGE2 administered as a vaginal tablet...
  75. ncbi Vaginal micronized progesterone in continuous hormone replacement therapy. A prospective randomized study
    S Ferrero
    Department of Obstetrics and Gynecology, University of Genoa, Genoa, Italy
    Minerva Ginecol 54:519-30. 2002
    ..Metabolic and tissue effects of the various progestins vary with dosage and route of administration. This study was performed to evaluate the effects of selected progestins on the lipidic profile and endometrial morphology...
  76. doi A thermosensitive vaginal gel formulation with HPgammaCD for the pH-dependent release and solubilization of amphotericin B
    Ye Tae Kim
    College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea
    Eur J Pharm Sci 41:399-406. 2010
    ..In conclusion, the thermosensitive vaginal gel might be useful in the delivery of an antifungal agent for local treatment...
  77. pmc Luteal Phase Support in assisted reproductive technology treatment: focus on Endometrin(R) (progesterone) vaginal insert
    Jerome H Check
    The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Camden, New Jersey, USA
    Ther Clin Risk Manag 5:403-7. 2009
    ..Larger studies are needed to compare side effects...
  78. pmc SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses
    Athe M N Tsibris
    Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 6:e28047. 2011
    ..These data suggest that breakthrough infections most likely result from incomplete viral inhibition and not the selection of MVC-resistant variants...
  79. ncbi Induction of labor by prostaglandin E(2) in relation to the Bishop score
    B Kemp
    Department of Obstetrics and Gynecology, Technical University Hospital of Aachen, Aachen, Germany
    Int J Gynaecol Obstet 71:13-7. 2000
    ..To compare the effectiveness of prostaglandin E(2) intravaginal gel with the intracervical gel in patients with an unfavorable cervix...
  80. pmc Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days
    Jeremy P Nuttall
    International Partnership for Microbicides, 8401 Colesville Road, Suite 200, Silver Spring, MD 20910, USA
    Antimicrob Agents Chemother 52:909-14. 2008
    ..The persistence of biologically significant concentrations of dapivirine in vaginal and cervical tissues for >24 h supports the development of dapivirine as a microbicide for once daily application...
  81. pmc Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand
    Sara J Whitehead
    Thailand Ministry of Public Health U S Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
    PLoS ONE 6:e14831. 2011
    ..Few studies of microbicide acceptability among HIV-infected women have been done. We assessed Carraguard® vaginal gel acceptability among participants in a randomized, controlled, crossover safety trial in HIV-infected women in Thailand...
  82. pmc Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms
    Maria Cristina Bonferoni
    Department of Pharmaceutical Chemistry, School of Pharmacy, University of Pavia, Pavia, Italy
    AAPS PharmSciTech 7:104. 2006
    ..This test demonstrated that the lactate release is mainly due to ionic displacement...
  83. ncbi Termination of second and early third trimester pregnancy: comparison of 3 methods
    I Bani-Irshaid
    Department of Obstetrics and Gynaecology, King Hussein Medical Centre, Amman, Jordan
    East Mediterr Health J 12:605-9. 2006
    ..5 hours). However, Foley catheter as a method of termination of pregnancy in second and early third trimester is safe and inexpensive, and its efficacy can be enhanced with the use of traction to give similar results to prostaglandin E2...
  84. pmc Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception
    Regine Sitruk-Ware
    Population Council, Center for Biomedical Research, New York, NY 10021, USA
    Contraception 75:454-60. 2007
    ....
  85. doi Endometrial safety of ultra-low-dose estradiol vaginal tablets
    James Simon
    Women s Health and Research Consultants, Washington, DC 20036, USA
    Obstet Gynecol 116:876-83. 2010
    ..To evaluate the endometrial hyperplasia and carcinoma rate after 52-week treatment with ultra-low-dose 10-microgram 17β-estradiol vaginal tablets in postmenopausal women with vaginal atrophy...
  86. ncbi Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis
    Sarah L Kieweg
    Department of Biomedical Engineering, Duke University, Box 90281, Durham, North Carolina 27708, USA
    J Pharm Sci 93:2941-52. 2004
    ..This study introduces a simple methodology for comparing trial formulations and relating their flows to gel constituents and physical properties. It also suggests differences in coating by current commercial gels...
  87. ncbi Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release cream (1, 2 and 4%) with placebo site-release vaginal cream
    A Del Palacio
    Department of Clinical Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Mycoses 43:355-65. 2000
    ..7% in group B, 16% in group C and 51.3% in group D. There was a significant difference in the overall ineffective treatment when C and D groups were compared with placebo (P = 0.01 and P = 0.003, respectively)...
  88. doi Randomised double-blind trial of the effect of vitamin C on dyspareunia and vaginal discharge in women receiving doxycycline and triple sulfa for chlamydial cervicitis
    Marjan Khajehei
    Namazi Sq Fatemeh PBUH College of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
    Aust N Z J Obstet Gynaecol 49:525-30. 2009
    ..Chlamydia trachomatis is the most common bacterial cause of cervicitis...
  89. pmc An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis
    Larry S Seidman
    Philadelphia Women s Research, Philadelphia, PA 19114, USA
    Infect Dis Obstet Gynecol 13:197-206. 2005
    ..The objective of this study was to compare the time to symptomatic relief of vulvovaginal candidiasis (VVC) with butoconazole nitrate 2% Site Release vaginal cream (Gynazole-1) and oral fluconazole 150 mg tablets (Diflucan)...
  90. ncbi Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes
    Atef Darwish
    Department of Obstetrics and Gynecology, Assiut University Hospital, Assiut, Egypt
    J Obstet Gynaecol Res 33:781-7. 2007
    ..To estimate the efficacy of different therapeutic modalities on proven cases of bacterial vaginosis (BV) in patients at high risk of preterm labor and premature rupture of membranes...
  91. pmc A brief sexual barrier intervention for women living with AIDS: acceptability, use, and ethnicity
    D L Jones
    The University of Miami School of Medicine, Miami, Florida 33136, USA
    J Urban Health 78:593-604. 2001
    ..Exposure to this pilot behavioral intervention was associated with increased acceptability and use of chemical barriers without decreased use of male condoms...
  92. doi Delivery course of macerated stillborn fetuses in the third trimester
    Dubravko Habek
    Department of Obstetrics and Gynecology, School of Medicine, Sveti Duh General Hospital Zagreb, Zagreb, Croatia
    Fetal Diagn Ther 24:42-6. 2008
    ..We present and discuss delivery (maternal and fetal) outcome of macerated stillbirths in the third trimester...
  93. ncbi Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets
    P Mastromarino
    Institute of Microbiology, University La Sapienza, Roma, Italy
    J Appl Microbiol 93:884-93. 2002
    ..To characterize and select Lactobacillus strains for properties that would make them a good alternative to the use of antibiotics to treat human vaginal infections...
  94. doi Treatment considerations for bacterial vaginosis and the risk of recurrence
    Judy Y Chen
    Health Benchmarks, Inc, IMS Health, Woodland Hills, California 91367, USA
    J Womens Health (Larchmt) 18:1997-2004. 2009
    ..The purpose of this study was to investigate BV recurrence rates and rates of acquiring vulvovaginal candidiasis (VVC) after different BV treatments in a commercially insured population...
  95. ncbi Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans
    H Yesim Karasulu
    Department of Pharmaceutical Technology, Faculty of Pharmacy, Ege University, Bornova, Izmir 35100, Turkey
    Farmaco 59:163-7. 2004
    ..These results indicated that a new bioadhesive vaginal tablet formulations might be further developed for safe convenient and effective treatment of vaginal candidasis...
  96. doi Prevalence and management of non-albicans vaginal candidiasis
    Nalin Hettiarachchi
    Department of Genitourinary Medicine, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK
    Sex Transm Infect 86:99-100. 2010
    ..In this paper, the authors review the prevalence of non-albicans candida over the past 5 years, and assess the efficacy of amphotericin and flucytosine vaginal cream in the treatment of non-albicans VVC...
  97. pmc Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria
    Vera Halpern
    Family Health International, Research Triangle Park, North Carolina, United States of America
    PLoS ONE 3:e3784. 2008
    ..This trial evaluated the safety and effectiveness of 6% cellulose sulfate vaginal gel in preventing male-to-female vaginal transmission of HIV, gonorrhea and chlamydial infection...
  98. pmc Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:beta-cyclodextrin complex
    Erem Bilensoy
    Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 06100 Ankara Turkey
    AAPS PharmSciTech 7:E38. 2006
    ..2% hydroxypropylmethylcellulose in Pluronic F127 gel (20%) providing continuous and prolonged release of active material above MIC values...
  99. doi Vaginal gel adsorption and retention by human vaginal cells: visual analysis by means of inorganic and organic markers
    Pier Carlo Braga
    Department of Pharmacology, School of Medicine, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy
    Int J Pharm 373:10-5. 2009
    ....
  100. doi A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety
    Ernst Rainer Weissenbacher
    Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe, LMU München Grosshadern, Munich, Germany
    Gynecol Obstet Invest 73:8-15. 2012
    ..To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin®) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV)...
  101. doi Contraceptive efficacy and safety of HerbOshield™ vaginal gel in rats
    Kamalinder K Singh
    C U Shah College of Pharmacy, Shreemati Nathibai Damodar Thakersey Women s University, Santacruz West, Mumbai 400049, India
    Contraception 85:122-7. 2012
    ..The synthetic agents available as spermicides produce severe side effects. Hence, there is a need to replace these agents with safe and effective agents such as plant-based contraceptive agents...

Research Grants65

  1. Vaginal Gel to Enhance Lubrication & Sperm Function
    JOANNA ELLINGTON; Fiscal Year: 2003
    ....
  2. Single and multi-component biguanide-based microbicides
    Mohamed Labib; Fiscal Year: 2007
    ....
  3. Non-Toxic Gel to Treat Vulvovaginal Candidiasis
    Charles Gauntt; Fiscal Year: 2006
    ..Annual costs for treating WC in the U.S. are estimated at $1.8 billion. ..
  4. Multitargeted Microbicide Combinations to Block HIV
    Betsy Herold; Fiscal Year: 2006
    ..The proposed comprehensive preclinical evaluation of combinations and clinical evaluation of PRO 2000 will lay the groundwork for future clinical trials with optimal combinations. ..
  5. HIV PREVENTION TRIAL UNITS
    Kenneth Mayer; Fiscal Year: 2007
    ..We will continue our leadership work in community education and the engagement of diverse communities in HIV prevention initiatives. ( ..
  6. Enhancing HIV Prevention Among High-Risk HIV+ Men
    Kenneth Mayer; Fiscal Year: 2007
    ..Participants will then be followed every three months for one year, integrating PCM and/or prevention booster sessions to their HIV care visits. ..
  7. Assessing & Improving the Measurement of Sexual Behavior
    Barbara Mensch; Fiscal Year: 2007
    ..abstract_text> ..
  8. Centers for Innovative Research to Control AIDS
    Wafaa El Sadr; Fiscal Year: 2007
    ..administrative component: ..
  9. Fragile X Premutations Among Women Diagnosed with Diminished Ovarian Reserve
    Lisa Pastore; Fiscal Year: 2007
    ....
  10. BIOPHYSICAL MECHANISMS IN LEUKOCYTES AND MELANOCYTES
    STEPHEN MALAWISTA; Fiscal Year: 1993
    ....
  11. Cooporative Contraceptive Research Center
    Regine Sitruk Ware; Fiscal Year: 2007
    ..The overall goal is to explore the prospect of the Adjudin-FSH mutant conjugate's candidacy as a male contraceptive, by targeting germ cell adhesion. Alternative delivery routes will be studied. ..
  12. HIV PREVENTION TRIAL UNIT (PRIDE NYC PROGRAM)
    Wafaa El Sadr; Fiscal Year: 2006
    ..abstract_text> ..
  13. Resolution of Gouty Inflammation
    STEPHEN MALAWISTA; Fiscal Year: 2007
    ..We suggest further that this reprogramming of lipid mediators may explain in part the action of therapeutic agents such as colchicine, and could lead to better treatment for this condition. ..
  14. TUBERCULOSIS ADHERENCE PARTNERSHIP ALLIANCE STUDY
    Wafaa El Sadr; Fiscal Year: 2004
    ..abstract_text> ..
  15. SEX HORMONES AND BODY FLUID REGULATION
    NINA STACHENFELD; Fiscal Year: 2003
    ....